Curium in the United Kingdom & Ireland A legacy of excellence in nuclear medicine
In the UK & Ireland, Curium supports healthcare professionals with high-quality radiopharmaceutical solutions for diagnostic imaging and scale up our diagnostics and into radiotherapeutics when appropriate. With an MIA recently issued for both our newly opened site in Oxford and Hammersmith, we provide access to diagnostics nationwide and are set up to grow the business and scale up into targeted therapies.
Dedicated employees
About Curium in the United Kingdom & Ireland
In the UK, Curium is a member of the Ethical Medicines Industry Group
With strong regulatory expertise, reliable distribution, and a commitment to quality and safety, Curium plays an important role in ensuring consistent access to nuclear medicine products that support patient diagnosis and treatment across both countries.
Curium Products in the United Kingdom & Ireland
Comprehensive radiopharmaceutical portfolio
Curium offers innovative radiopharmaceutical solutions designed to support accurate diagnosis in nuclear medicine. Key products such as Pylclari and Pylclari AI which helps healthcare professionals improve imaging efficiency, clinical decision-making, and patient care through advanced diagnostic technologies.
Our Products page is unavailable
Details to our global products will be coming soon
Cardiology 
Infectious Diseases 
Neurology 
Oncology 
Radionuclide Generators 
Pulmonology 
Nephrology 
Endocrinology 
Urology 
Musculoskeletal 
Gastroenterology 
Hematology Ireland online ordering and product release system
Curium operates a fully validated online ordering and product release system for radiopharmaceuticals, compliant with 21 CFR Part 11 and EudraLex Annex 11. The platform allows users to place orders, manage deliveries, track order status, access product release certificates, receive automated notifications throughout the product lifecycle, and instantly acknowledge product receipt through secure online access.
Curium UK updates its Carbon Reduction Plan and reaffirms its Net Zero ambition
Curium UK is committed to reducing the carbon emissions associated with its operations and value chain.
Our updated Carbon Reduction Plan sets out the actions being taken to reduce emissions across our UK activities. It supports our ambition to achieve Net Zero emissions by 2045, in line with the NHS Net Zero Supplier Roadmap.
Modern Slavery Statement – UK
This Modern Slavery Statement sets out Curium Pharma UK Ltd.’s commitment to conduct business in a responsible and ethical manner, with respect for internationally recognized human rights, as well as the measures taken to prevent modern slavery and human trafficking in its operations and supply chains.
A World of Opportunities. Powered by Purpose.
Discover how your talent can thrive at Curium — where global purpose meets local impact, and every role helps shape the future of nuclear medicine.
Curium Locations in the United Kingdom and Ireland
Dublin
Sales Offices
Dublin, Ireland
A94 E4X7
London (Hammersmith)
PET Radiopharmacies
Burlington Danes Building
Imperial College London (Hammersmith Campus)
Du Cane Road
London W12 0NN
UK
London (University College Hospital)
PET Radiopharmacies, SPECT Radiopharmacies
235 Euston Road
London NW1 2BU
UK
Oxford
PET Radiopharmacies, SPECT Radiopharmacies
The Radiopharmacy Unit, Block 4
The Churchill Hospital
Headington
Oxford OX3 7LE
United Kingdom
Portsmouth
Sales Offices
Lakeside, North Harbour
Western Road, Portsmouth
Hampshire PO6 3EN
United Kingdom
United Kingdom
Country Headquarters
London SW1Y 5NQ
United Kingdom